Contact Us
If you’d like to chat about Genoox in more detail, complete this form
and we’ll get back to you.
If you’d like to chat about Genoox in more detail, complete this form
and we’ll get back to you.
Thermo Fisher Scientific has upgraded its leading Applied Biosystems Chromosome Analysis Suite (ChAS) software through a collaboration with Genoox, a community-driven genomic data company. ChAS users will be able to access Genoox’s cloud-based AI platform, Franklin, with the launch of CytoScan Automated Interpretation and Reporting (AIR) solution, making cytogenetic research data analysis easier.
Read More
The seasoned technology executive and former president of 23andMe will enrich Genoox's mission to build the most diverse genomic database to support point of care geneticists
Read More
Creating the world’s largest genomic database powered by real world evidence answering any clinical and genetic questions by harnessing the power of the community to and serving healthcare professionals, clinicians, genetic experts and pharma to enhance patient care.
Read More
Demonstrating the clinical potential of the AVITI system for rare and undiagnosed disease research, using whole genome sequencing.
Read More
Our story about building the world’s largest, most diverse real-world evidence dataset to answer any genomic question.
Read More
Genoox leverages its community-driven AI software to enable analysis and facilitate interpretation of genetic and genomic testing spanning clinical and research domains.
Read More
This partnership will expand on the information currently available to establish and improve advanced testing to accurately diagnose complex diseases found in women
Read More
The company’s mission — to democratize healthcare — will help health systems provide more standardized care, regardless of location, which can aid in better patient outcomes
Read More
Genoox seeks to advance precision medicine through its next-generation sequencing technology and genomic data analytics.
Read More
PALO ALTO, Calif. – (Business Wire) – Genoox, a genomic analysis company making it easier for doctors, clinicians and researchers to analyze and act on genetic sequencing results by applying various clinical applications, today announced it closed a $6 million funding round. The round was led by Triventures, a venture capital fund that invests in…
Read More
NEW YORK (GenomeWeb) – Genoox announced today that it has partnered with Bionano Genomics to develop a genome informatics workflow, which will integrate and annotate Bionano’s structural variant calls with sequencing data within the Genoox platform.
Read More
The Genoox platform helps the team apply standards for both security policies and sharing data across the community, which has the benefit of increasing cooperation between organizations.
Read More
Genoox will analyze genetic data captured and provide actionable insights to hospitals, clinical labs and researchers throughout Israel
Read More
Genoox has developed an artificially intelligent engine to classify genetic variants, based on American College of Medical Genetics and Genomics guidelines. This platform provides data analytics services to physicians and researchers looking to integrate genomic sequencing information into clinical workflows, and Genoox has said its technology can lower sequencing costs by as much as 90…
Read More
If you’d like to chat about Genoox in more detail, complete this form
and we’ll get back to you.
